BIOLIFE SOLUTIONS INC (BLFS) - Dilution Analysis

10-Q filing | 49.2M shares outstanding

10-Q filing | 47.9M shares outstanding

10-Q filing | 47.8M shares outstanding

10-Q filing | 47.1M shares outstanding

10-K filing | 46.1M shares outstanding

10-Q filing | 46.2M shares outstanding

10-Q filing | 46.0M shares outstanding

10-Q filing | 45.4M shares outstanding

10-K filing | 43.7M shares outstanding

S-3 filing: This S-3 filing registers 927,165 shares of common stock offered by a selling stockholder, which were issued on October 19, 2023, pursuant to a purchase agreement related to a private placement. The company will not receive any proceeds from the sale.

S-3 filing: The company files an S-3 to register the offering of common stock, preferred stock, and warrants through various methods, including rights offerings and sales through underwriters or directly to investors.

10-Q filing | 43.6M shares outstanding

8-K filing: BioLife Solutions, Inc. completed a private placement with Casdin Partners Master Fund, L.P., selling 927,165 shares of common stock at $11.19 per share for gross proceeds of $10,374,976.35 on October 19, 2023. ($10.37M proceeds)

10-Q filing | 43.4M shares outstanding

10-Q filing | 43.0M shares outstanding

10-K filing | 42.5M shares outstanding

10-Q filing | 42.6M shares outstanding

10-Q filing | 42.5M shares outstanding

10-Q filing | 42.0M shares outstanding

10-K filing | 38.5M shares outstanding

10-Q filing | 40.9M shares outstanding

10-Q filing | 40.4M shares outstanding

10-Q filing | 33.2M shares outstanding

10-K filing | 33.0M shares outstanding

8-K filing: BioLife Solutions, Inc. will issue 6,646,870 newly issued shares of common stock to the stockholders of Global Cooling, Inc. as part of a merger agreement.

10-Q filing | 31.6M shares outstanding

8-K filing: BioLife Solutions, Inc. entered into a Stock Purchase Agreement to acquire SciSafe Holdings, Inc., involving an initial cash payment of $15,000,000 and the issuance of common stock valued at $15,000,000 at closing, with potential earnout payments of up to 626,000 additional shares of common stock based on SciSafe's revenue targets.

10-Q filing | 26.0M shares outstanding

8-K filing: Biolife Solutions, Inc. closed a public offering of common stock on July 7, 2020, selling 5,951,250 shares at $14.50 per share, resulting in gross proceeds of approximately $86.3 million. ($86.3M proceeds)

10-Q filing | 26.0M shares outstanding

8-K filing: BioLife Solutions, Inc. closed a financing transaction with Casdin Partners Master Fund, L.P., issuing 1,904,762 shares of common stock at $10.50 per share, resulting in gross proceeds of $20,000,000. ($20.0M proceeds)

10-K filing | 24.0M shares outstanding

8-K filing: The Company entered into a share purchase agreement with Casdin Capital LLC for $20 million at $10.50 per share, and issued approximately 2.7 million shares to warrant holders via cashless exercise, eliminating approximately 3.9 million warrants. ($21.0M proceeds)